Biomarker News and Research

RSS

A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule.

Food taboos can lead to nutrient deficiencies, malnutrition for mothers and unborn children

One in five pregnant women in Ethiopia are deliberating staying under nourished for fear of fetal deformities and giving birth to big babies, public health researchers say.

19 Apr 2023

The effect of moderate intensity exercise in pregnant women with cardiovascular disease

Researchers assess the effect of moderate-intensity exercise in pregnant women with cardiovascular disease.

19 Apr 2023

Study reveals DCAF1 protein's role in colon cancer development through EZH2 phosphorylation

A recent study reveals that DCAF1 is overexpressed and phosphorylates EZH2 in colon cancer cells.

18 Apr 2023

Is there a correlation between acute and chronic red wine intake and health?

Researchers examined the correlations between acute and chronic red wine (RW) intake and health.

18 Apr 2023

Prenatal musical exposure increases baby's ability for neuronal encoding of speech sounds

When pregnant women sing to their babies or listen to music on loudspeakers during their pregnancy, babies are born with a better ability for neuronal encoding of speech sounds.

12 Apr 2023

Immunotherapy response in patients with advanced melanoma depends on prior treatments

Research led by scientists at UCLA Jonsson Comprehensive Cancer Center found that responses to a type of immunotherapy called PD-1 checkpoint blockade in patients with advanced melanoma depended on whether or not they had previously received another immunotherapy – CTLA-4 blockade – as well as other factors.

10 Apr 2023

Immune checkpoint inhibitor treatment is facilitated by dietary tryptophan metabolite synthesized by Lactobacillus reuteri

Researchers highlight how dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment.

10 Apr 2023

Study opens new possibilities of tailoring radiopharmaceutical treatment to neuroendocrine cancer patients

A simple blood draw can provide physicians with valuable information that can determine if peptide receptor radionuclide therapy (PRRT) is likely to be effective in a patient with neuroendocrine cancer.

7 Apr 2023

The association between omega-3 polyunsaturated fatty acid intake and reduced risk of Alzheimer's disease

Researchers evaluated the association between omega-3 polyunsaturated fatty acids intake, cognitive decay, and dementia.

7 Apr 2023

Mediterranean diet and the modulation of mitochondrial function

Researchers reviewed the current knowledge related to the Mediterranean diet (MedDiet) and the role of mitochondria concerning health outcomes.

7 Apr 2023

How nanomedicine is revolutionizing care for cardiovascular disease

Researchers review recent advancements in nanomedicine treatment options for cardiovascular disease.

6 Apr 2023

Combinatorial biomarker predicts response to immunotherapy in kidney cancer patients

The number of immune cells in and around kidney tumors, the amount of dead cancer tissue, and mutations to a tumor suppressor gene called PBRM1 form a biomarker signature that can predict — before treatment begins — how well patients with kidney cancer will respond to immunotherapy, according to new research directed by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.

6 Apr 2023

Study examines the causal role of insomnia symptoms on 11,409 health related-symptoms

Researchers performed Mendelian randomization phenome-wide association study of insomnia symptoms using 11,409 outcome variables.

6 Apr 2023

Parkinson's linked to higher levels of pheomelanin in brain: Could it be a biomarker or treatment target?

Researchers discover that the substantia nigra of individuals with Parkinson’s disease had a higher concentration of pheomelanin.

6 Apr 2023

Long-COVID fatigue reduced by over 50% in active individuals compared to sedentary

A recent Diagnostics journal study determined the impact of physical activity on sleep, fatigue, and cognitive modifications in individuals affected by long-COVID. This study investigates how long-COVID differentially affects individuals with active lives from those with sedentary lifestyles.

5 Apr 2023

Mosaic Therapeutics closes $28m series A funding and appoints Brian Gladsden as CEO

Mosaic Therapeutics, an oncology therapeutics company dedicated to resolving cancer’s complexity to power new treatments for patients, today announced the close of its $28 million series A funding round.

From Mosaic Therapeutics 4 Apr 2023

CRISPR screens reveal genetic determinants of PARP inhibition in prostate cancer

Prostate cancer tumors harboring BRCA1/2 mutations are exceptionally sensitive to PARP inhibitors, while genomic alterations in other DNA damage response (DDR) genes are less responsive.

4 Apr 2023

New model for proteomic cardiovascular risk assessment among chronic kidney disease patients

Chronic kidney disease (CKD) is a strong cardiovascular risk factor and is often accompanied by hypertension and diabetes. Despite the disease's prevalence - 10 percent of individuals across the globe suffer from CKD - there are limited tools for measuring cardiac risk for CKD patients, until now.

4 Apr 2023

Blood-based biomarkers for Alzheimer’s disease could make diagnostic workup more accurate, cost-effective

An international research team led by the HUG and the UNIGE has shown that amyloid and tau blood-based biomarkers are highly correlated with the corresponding biomarkers used so far for the diagnosis of Alzheimer's disease.

4 Apr 2023

Mosaic Therapeutics closes $28m series A funding and appoints Brian Gladsden as CEO

Company developing targeted oncology therapies spun out of world-leading research at the Wellcome Sanger Institute, in collaboration with the Netherlands Cancer Institute.

From Mosaic Therapeutics 4 Apr 2023

Biomarker News and Research

Further Reading

Food taboos can lead to nutrient deficiencies, malnutrition for mothers and unborn children

The effect of moderate intensity exercise in pregnant women with cardiovascular disease

Study reveals DCAF1 protein's role in colon cancer development through EZH2 phosphorylation

Is there a correlation between acute and chronic red wine intake and health?

Prenatal musical exposure increases baby's ability for neuronal encoding of speech sounds

Immunotherapy response in patients with advanced melanoma depends on prior treatments

Immune checkpoint inhibitor treatment is facilitated by dietary tryptophan metabolite synthesized by Lactobacillus reuteri

Study opens new possibilities of tailoring radiopharmaceutical treatment to neuroendocrine cancer patients

The association between omega-3 polyunsaturated fatty acid intake and reduced risk of Alzheimer's disease

Mediterranean diet and the modulation of mitochondrial function

How nanomedicine is revolutionizing care for cardiovascular disease

Combinatorial biomarker predicts response to immunotherapy in kidney cancer patients

Study examines the causal role of insomnia symptoms on 11,409 health related-symptoms

Parkinson's linked to higher levels of pheomelanin in brain: Could it be a biomarker or treatment target?

Long-COVID fatigue reduced by over 50% in active individuals compared to sedentary

Mosaic Therapeutics closes $28m series A funding and appoints Brian Gladsden as CEO

CRISPR screens reveal genetic determinants of PARP inhibition in prostate cancer

New model for proteomic cardiovascular risk assessment among chronic kidney disease patients

Blood-based biomarkers for Alzheimer’s disease could make diagnostic workup more accurate, cost-effective

Mosaic Therapeutics closes $28m series A funding and appoints Brian Gladsden as CEO

Industry Focus eBook - Protein Analysis (3rd edition) eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo